To screen ETFs by asset class, performance, yield and more, check out the
has superior RNA technology.
has superior RNA delivery tech (via MIT collaboration). Acquire both and potential is limitless
Add a reply...
Latest StockTalks »
people get SRPT breaking news and analysis by email alert.
Get email alerts on SRPT »
Sarepta Therapeutics, Inc.
Get latest price
From other sites
Sarepta Therapeutics : FDA Has Filed Eteplirsen NDA for the Potential Treatment of Duchenne Muscular Dystrophy for Patients Amenable to Exon 51...
at 4-traders.com (Aug 31, 2015)
Sarepta Therapeutics : Receives Rare Pediatric Disease Designation From FDA for Eteplirsen for the Potential Treatment of Duchenne Muscular Dystrophy
at 4-traders.com (Aug 21, 2015)
Sarepta Therapeutics Names Henri Termeer as Advisor to the Company
at 4-traders.com (Jul 12, 2015)
Sarepta Therapeutics : Announces Fourth Quarter and Full-Year 2014 Financial Results and Recent Corporate Developments
at 4-traders.com (Mar 24, 2015)
10 Biotech Stories You Might've Missed This Week
at Benzinga.com (Jan 15, 2015)
Xignite quote data
© 2015 Seeking Alpha